These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2856771)

  • 21. Response of arterial blood pressure, plasma renin activity and plasma aldosterone concentration to long-term administration of captopril in patients with severe, treatment-resistant malignant hypertension.
    McCaa CS; Langford HG; Cushman WC; McCaa RE
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():371s-373s. PubMed ID: 396084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients.
    Braith RW; Mills RM; Wilcox CS; Davis GL; Hill JA; Wood CE
    J Am Coll Cardiol; 2003 Feb; 41(3):426-32. PubMed ID: 12575970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients.
    Whitman HH; Case DB; Laragh JH; Christian CL; Botstein G; Maricq H; Leroy EC
    Arthritis Rheum; 1982 Mar; 25(3):241-8. PubMed ID: 6279117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca.
    Lacour C; Cazaubon C; Roccon A; Segondy D; Wagnon J; Nisato D
    J Hypertens Suppl; 1989 Apr; 7(2):S33-5. PubMed ID: 2666612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of renal function in patients with accelerated malignant nephrosclerosis on maintenance dialysis with management of blood pressure by captopril.
    Mourad G; Mimran A; Mion CM
    Nephron; 1985; 41(2):166-9. PubMed ID: 3900778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurohumoral mechanisms regulating renal blood circulation in patients with hypertension undergoing captopril block of angiotensin-converting enzyme].
    Almazov VA; Ametov AS; Shliakhto EV; Dolgova IB; Pushkarev AA
    Ter Arkh; 1989; 61(8):13-5. PubMed ID: 2573961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of malignant hypertension with refractory cardiac failure to captopril: A case report.
    Levin L; Logan K
    S Afr Med J; 1980 Aug; 58(5):217-8. PubMed ID: 6996155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saluretics and converting-enzyme blockade in the treatment of resistant hypertension.
    Delin K; Aurell M; Herlitz H
    Acta Pharmacol Toxicol (Copenh); 1984; 54 Suppl 1():53-6. PubMed ID: 6324541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers.
    de Gasparo M; Cumin F; Nussberger J; Guyenne TT; Wood JM; Menard J
    Br J Clin Pharmacol; 1989 May; 27(5):587-96. PubMed ID: 2667598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic and humoral effects of single intravenous doses of captopril in normal subjects.
    Nussberger J; Waeber G; Bidiville J; Waeber B; Brunner HR
    Clin Exp Hypertens A; 1987; 9(2-3):345-9. PubMed ID: 3301079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Captopril].
    Mohr K
    Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1899-900. PubMed ID: 8287781
    [No Abstract]   [Full Text] [Related]  

  • 32. Captopril and frusemide in severe drug-resistant hypertension.
    White NJ; Rajagopalan B; Yahaya H; Ledingham JG
    Lancet; 1980 Jul; 2(8186):108-10. PubMed ID: 6105292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute electrocardiographic effects of captopril in the initial treatment of malignant or severe hypertension.
    Abe I; Kawasaki T; Kawazoe N; Omae T
    Am Heart J; 1983 Sep; 106(3):558-62. PubMed ID: 6349320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral converting enzyme inhibitor in malignant hypertension.
    Griswold W; McNeal R; O'Connor D; Reznik V; Mendoza S
    Arch Dis Child; 1982 Mar; 57(3):235-7. PubMed ID: 6280623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical issues when initiating captopril therapy in chronic heart failure. What is the appropriate dose and how long should patients be observed?
    McLay JS; McMurray J; Bridges A; Struthers AD
    Eur Heart J; 1992 Nov; 13(11):1521-7. PubMed ID: 1464341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of preoperative renin-angiotensin system blockade on hypertension following coronary surgery.
    Colson P; Grolleau D; Chaptal PA; Ribstein J; Mimran A; Roquefeuil B
    Chest; 1988 Jun; 93(6):1156-8. PubMed ID: 3286140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Captopril, angiotensin II, and sodium in blood-pressure regulation.
    Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Lancet; 1979 May; 1(8126):1140. PubMed ID: 86858
    [No Abstract]   [Full Text] [Related]  

  • 38. Brain Natriuretic Peptide Counteracting the Renin-angiotensin-aldosterone System in Accelerated Malignant Hypertension.
    Nakagawa H; Mizuno Y; Harada E; Morikawa Y; Kuwahara K; Saito Y; Yasue H
    Am J Med Sci; 2016 Nov; 352(5):534-539. PubMed ID: 27865304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Captopril in severe childhood hypertension--reversible anaemia with high dosage.
    Verhaaren HA; Vande Walle J; Devloo-Blancquaert A
    Eur J Pediatr; 1986 Apr; 144(6):554-6. PubMed ID: 3519229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refractory hypertension in childhood--efficacy of captopril therapy.
    Yamagishi M; Kaneko M; Chiba K; Ohji T; Kohri T
    J UOEH; 1987 Dec; 9(4):401-10. PubMed ID: 3326101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.